Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice - Test2 - elhamkhani - TriplyDB

Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice

Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice

http://www.wikidata.org/entity/Q34349192

about

Neuroprotection mediated by inhibition of calpain during acute viral encephalitis Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration.Prepulse inhibition in HIV-associated neurocognitive disorders.Designer adiponectin receptor agonist stabilizes metabolic function and prevents brain injury caused by HIV protease inhibitors Humanized mouse models for HIV-1 infection of the CNS.Lopinavir/Ritonavir Impairs Physical Strength in Association with Reduced Igf1 Expression in Skeletal Muscle of Older Mice.Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance.Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance.Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.Predicting neurological Adverse Drug Reactions based on biological, chemical and phenotypic properties of drugs using machine learning models.Leptin regulates amyloid β production via the γ-secretase complex HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.Effect of antiretroviral therapy use and adherence on the risk of hyperlipidemia among HIV-infected patients, in the highly active antiretroviral therapy era.Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice.Impact of current antiretroviral therapies on neuroAIDS Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications

P2860

Q26700065-C9746153-6945-4814-A0A2-C0994202E047 Q30397743-384C3554-C587-42F5-AD23-BD13841C12D2 Q30451688-E7F0DAAF-F634-4233-AE1A-1CB14C2D09ED Q30625328-FE1B0478-9384-40BF-9E56-C0226496D776 Q35567215-F468F035-6565-46C3-9B69-FCB1925AF609 Q35915493-E1FBDA0E-E73C-4A10-B5B3-E23CBD053D40 Q36104280-E76FC5E0-4BF0-4269-AC8C-FCD6FDCE2AFD Q36169735-0987B6DE-8272-40AF-8AA5-1F66ED183377 Q36517668-EE71DF34-D88D-42C6-88A0-20909940A66E Q37592018-EC0069E9-8A5D-471C-B61D-ABE8BE39466C Q37691000-3EEBC13E-3D22-4C04-BA30-3EB7A4C801AB Q38609997-39EEA57A-8F2B-4666-BEBB-603645759ABF Q39157047-C55878E1-0984-40A7-83E3-9092E76C163A Q39218926-3270F444-FF37-448D-97F5-31222996A8FB Q40404098-2CB800E8-4DE2-405E-A7EA-E8488DA300FD Q47112253-E9F6745C-0176-4E74-9230-C9A1F2994F60 Q50054188-E88C0172-2DB6-4C92-A290-A81DB0E52639 Q57831860-6168368E-1474-48A0-A8D4-F7E51F3C3CAF Q58692622-B3035478-1E1F-4DA5-AAE0-EBD75509EB5F Q58764782-00D357CD-49FF-4118-848E-F75FC18D332E

P2860

Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice

http://www.wikidata.org/entity/Q34349192

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@ast

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@en

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@nl

type

label

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@ast

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@en

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@nl

prefLabel

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@ast

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@en

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@nl

P1433

Q34349192-0FF33B76-194F-4A29-B8BD-89632EEF9E45

P1476

Q34349192-1C49BEDB-A15D-42FB-89E0-6B1CC9CD584F

P2093

Q34349192-0BF1A6D6-FA18-44D7-86AF-9415EABBC1DE

Q34349192-1A4E26FC-98D9-47E4-AB0A-CA7DC643E2CA

Q34349192-1F60C7B5-6178-44FD-8759-2CA09DB8E709

Q34349192-2296A4A4-35FA-47E0-B58E-2A4379EA6EBF

Q34349192-6E10BE52-F57A-486F-B200-1C25FD4BABF8

Q34349192-753CA01A-D7ED-417B-BCC0-CE2D9C4706E1

Q34349192-9AC7FDC4-7D50-43CF-9CC7-8CE4755529BC

Q34349192-C6F40E27-FED6-4088-AD95-B08721CE0BC4

Q34349192-E3F8D35A-ED7F-4EA9-B211-FB9B8AACC80E

Q34349192-F84014DD-3466-4AF1-903B-701E3872998B

P2860

Q34349192-00CB054D-4B3E-42FE-A4E2-15C3D8675E02

Q34349192-06FDD689-AF86-4A5A-96BB-72BCCEB11DF1

Q34349192-07860458-20AA-4843-A6BC-2E3C8CC37065

Q34349192-144ADEEC-13F3-4B4C-A5B1-CA79F050CDC4

Q34349192-1A6788C7-CA30-4AAC-81A7-BA6584E6EFBA

Q34349192-2205534C-BEA6-4813-8519-A3D5A23CCC79

Q34349192-2392D85A-8931-4F2A-A361-6CB650DC98BC

Q34349192-29B7B725-C680-45A7-B7C6-50F648AB28DE

Q34349192-2A3259E4-9DEA-451C-8FEE-E6A2E13A646C

Q34349192-2ADD8594-AD09-4F89-93D4-3A2BB272153B

P304

Q34349192-912ADBB3-3C82-4074-8FBA-4EF78C2DF0FD

P31

Q34349192-AE2AB7DA-1EC4-40EA-B215-25F1C62200EA

P356

Q34349192-F25046C1-D874-4818-B4C2-2D0450EA869A

P433

Q34349192-F7C11108-011C-4E44-A21C-6101328BABD9

P478

Q34349192-2EB194C5-D1DC-4A92-9EFC-79ECD1F0ABB1

P577

Q34349192-FAF51679-FC87-4BCA-BC17-DB7EEB961B2B

P5875

Q34349192-331BFC23-C098-4A72-88BA-2ADD97707485

P698

Q34349192-05201A40-60A0-47FF-8C7F-F8A8D91C9B7F

P932

Q34349192-B39D6E4E-6441-4D44-8E21-E26BC9990E01

P356

J.ANTIVIRAL.2010.10.006

P1433

Antiviral Research

P1476

Metabolic and neurologic conse ...... administration to C57BL/6 mice

@en

P2093

Alecia G Knight

http://www.w3.org/2001/XMLSchema#string

Annadora J Bruce-Keller

http://www.w3.org/2001/XMLSchema#string

Carmen Ruiz

http://www.w3.org/2001/XMLSchema#string

Donald K Ingram

http://www.w3.org/2001/XMLSchema#string

Indu Kheterpal

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Keller

http://www.w3.org/2001/XMLSchema#string

Michelle Domingue

http://www.w3.org/2001/XMLSchema#string

Paul J Pistell

http://www.w3.org/2001/XMLSchema#string

Romina M Uranga

http://www.w3.org/2001/XMLSchema#string

Sunita Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications

Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome

Expression of free fatty acid receptor GPR40 in the neurogenic niche of adult monkey hippocampus

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus

Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet

Leptin and the regulation of body weight in mammals

Dose translation from animal to human studies revisited

Identification and expression cloning of a leptin receptor, OB-R

HIV epidemiology and the effects of antiviral therapy on long-term consequences.

Development of a water-escape motivated version of the Stone T-maze for mice.

P304

334-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ANTIVIRAL.2010.10.006

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47533257

http://www.w3.org/2001/XMLSchema#string

P698

20970459

http://www.w3.org/2001/XMLSchema#string

P932

2991583

http://www.w3.org/2001/XMLSchema#string